» Articles » PMID: 39511560

Concomitant Parasite Infections Influence Tuberculosis Immunopathology and Favor Rapid Sputum Conversion of Pulmonary Tuberculosis Patients

Abstract

Immunopathology of human tuberculosis (TB) in a subgroup of patients is characterized by aberrantly high concentrations of inflammatory cytokines, for example Interleukin (IL)-6. Concomitant (co-)infections by parasites can affect host immunity, but the impact on immunopathology in TB patients is poorly defined. Here we characterized a group of patients with TB ( n = 76) from Ghana with different protozoan and helminth co-infections. Plasma cytokines were measured at the onset of disease and anti-mycobacterial treatment efficacy was monitored during disease course. A subgroup of TB patients had co-infections with protozoan (n = 19) or helminth (n = 16) parasites. Plasma analyses for candidate cytokines identified lower levels of IL-6 in parasite co-infected patients with TB. Moreover, it took less time for co-infected patients to become sputum-negative for Mycobacterium tuberculosis during treatment. These results indicated an influence of parasite co-infections on immunopathology in TB and suggested positive effects on treatment efficacy.

References
1.
Vivekanandan M, Adankwah E, Aniagyei W, Acheampong I, Yeboah A, Arthur J . Plasma cytokine levels characterize disease pathogenesis and treatment response in tuberculosis patients. Infection. 2022; 51(1):169-179. PMC: 9879809. DOI: 10.1007/s15010-022-01870-3. View

2.
Mabbott N . The Influence of Parasite Infections on Host Immunity to Co-infection With Other Pathogens. Front Immunol. 2018; 9:2579. PMC: 6237250. DOI: 10.3389/fimmu.2018.02579. View

3.
Oh J, Lee Y, Min K, Hur G, Yong Lee S, Kang K . Elevated interleukin-6 and bronchiectasis as risk factors for acute exacerbation in patients with tuberculosis-destroyed lung with airflow limitation. J Thorac Dis. 2018; 10(9):5246-5253. PMC: 6196218. DOI: 10.21037/jtd.2018.08.29. View

4.
Babu S, Nutman T . Helminth-Tuberculosis Co-infection: An Immunologic Perspective. Trends Immunol. 2016; 37(9):597-607. PMC: 5003706. DOI: 10.1016/j.it.2016.07.005. View

5.
Que Y, Hu C, Wan K, Hu P, Wang R, Luo J . Cytokine release syndrome in COVID-19: a major mechanism of morbidity and mortality. Int Rev Immunol. 2021; 41(2):217-230. PMC: 7919105. DOI: 10.1080/08830185.2021.1884248. View